About Lisa Foster

Articles by Lisa Foster

Treating Pediatric AML
Mar 13, 2024
The Importance Of Glucose Levels And Cancer Cells
Mar 11, 2024
Bexmarilimab–A Promising New Drug To Treat MDS, Currently in Clinical Trials
Mar 11, 2024
Bisantrene Combination Therapy A Promising Treatment For R/R AML
Mar 06, 2024
Vitamins C And D Benefit Patients During Intensive Chemotherapy
Mar 05, 2024
A New Study: Danvatirsen For AML
Mar 04, 2024
For DLBCL Patients Who Have Run Out of Options: Tafasitamab and Lenalidomide
Mar 04, 2024
Pediatric AML: What Does It Look Like?
Feb 28, 2024
Familial AML With The CEBPA Mutation
Feb 27, 2024
The Role Of Hypomethylating Agents
Feb 27, 2024
MDS and CCUS Post CAR-T Therapy for DLBCL
Feb 26, 2024
ASH 2023: Navitoclax And Ruxolitinib Trials to Treat Myelofibrosis
Feb 26, 2024
What Diet Should I Follow With Chronic Kidney Disease?
Feb 20, 2024
ASH 2023: Financial Outcomes For Transplant Vs. Non-Transplant Patients
Feb 19, 2024
Acute Kidney Injury (AKI) and Chronic Kidney Disease (CKD)
Feb 12, 2024
How DLBCL Affects The Body
Feb 12, 2024
ASH 2023: Venetoclax Combined With Azacitidine For High-Risk MDS
Feb 06, 2024
ASH 2023: IDH2 Mutation Affects Bone Marrow And AML Cells
Feb 06, 2024
Pulmonary Hypertension And Chronic Kidney Disease
Feb 02, 2024
Momelotinib: A New Treatment Option For Myelofibrosis
Feb 01, 2024
A New Compound To Treat Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Jan 26, 2024
A CMML Special Initiative Supports the Development of Innovative Treatment Options
Jan 18, 2024
ASH 2023: Cardiovascular Complications and Myelofibrosis
Jan 08, 2024
ASH 2023: Phase 1/2 Study Of Zilurgisertib Monotherapy And In Combination With Ruxolitinib For Anemic Myelofibrosis Patients
Jan 05, 2024